[go: up one dir, main page]

WO2011043564A3 - Composition containing black ginseng extracts for preventing or treating liver cancer - Google Patents

Composition containing black ginseng extracts for preventing or treating liver cancer Download PDF

Info

Publication number
WO2011043564A3
WO2011043564A3 PCT/KR2010/006744 KR2010006744W WO2011043564A3 WO 2011043564 A3 WO2011043564 A3 WO 2011043564A3 KR 2010006744 W KR2010006744 W KR 2010006744W WO 2011043564 A3 WO2011043564 A3 WO 2011043564A3
Authority
WO
WIPO (PCT)
Prior art keywords
black ginseng
liver cancer
preventing
composition containing
treating liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/006744
Other languages
French (fr)
Korean (ko)
Other versions
WO2011043564A2 (en
Inventor
김항종
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010800554591A priority Critical patent/CN102711779A/en
Publication of WO2011043564A2 publication Critical patent/WO2011043564A2/en
Publication of WO2011043564A3 publication Critical patent/WO2011043564A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a method for specifically increasing Rg3 ingredients from among the ginsenoside ingredients of black ginseng. The black ginseng extracts prepared by the method exhibit a high anticancer activity against human liver cancer cells. Further, it has been verified that the method of the present invention has the effect of decreasing the content of benzopyrene which is known to be mainly generated during heating.
PCT/KR2010/006744 2009-10-07 2010-10-04 Composition containing black ginseng extracts for preventing or treating liver cancer Ceased WO2011043564A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010800554591A CN102711779A (en) 2009-10-07 2010-10-04 Composition containing black ginseng extracts for preventing or treating liver cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0095003 2009-10-07
KR1020090095003A KR100972941B1 (en) 2009-10-07 2009-10-07 Composition comprising an extract of black ginseng for preventing or treating hepatoma

Publications (2)

Publication Number Publication Date
WO2011043564A2 WO2011043564A2 (en) 2011-04-14
WO2011043564A3 true WO2011043564A3 (en) 2011-09-01

Family

ID=42646131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/006744 Ceased WO2011043564A2 (en) 2009-10-07 2010-10-04 Composition containing black ginseng extracts for preventing or treating liver cancer

Country Status (3)

Country Link
KR (1) KR100972941B1 (en)
CN (1) CN102711779A (en)
WO (1) WO2011043564A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369638B1 (en) 2012-01-04 2014-03-06 주식회사 한국인삼공사 Methods for Preparing Red Ginseng with Prevented Body Crack
CN104873558A (en) * 2015-06-11 2015-09-02 北京凯宾鸿生物医药科技有限公司 Preparation method of black ginseng with high-content ginsenoside
CN107737146B (en) * 2017-11-21 2021-04-02 扬州大学 Bamboo ginseng slices and preparation method thereof
CN120789139B (en) * 2025-09-12 2025-12-26 广东万年青制药股份有限公司 Application of traditional Chinese medicine composition in preparation of anti-liver cancer drugs

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005089A (en) * 2002-11-15 2003-01-15 김항종 Manufacturing method of black ginseng and black rice
KR100600795B1 (en) * 2006-01-18 2006-07-19 (주) 흑삼코리아 Black ginseng and black ginseng concentrate with high content of ginsenosides
KR100692294B1 (en) * 2006-08-31 2007-03-12 박춘자 Manufacturing method of black ginseng extract excellent in anticancer effect against colorectal cancer
KR100729214B1 (en) * 2006-11-07 2007-06-19 (주)고려바이오홍삼 Manufacturing method of black ginseng and black ginseng prepared using the same
KR100754253B1 (en) * 2006-05-17 2007-09-03 충남대학교산학협력단 Novel black ginseng manufacturing method and composition containing same
KR20080106077A (en) * 2007-05-31 2008-12-04 박용진 Novel black red ginseng and preparation method thereof and composition containing same
KR20090093310A (en) * 2008-02-29 2009-09-02 강신정 Benzopyrene reduced red and black ginseng manufacturing method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101127279B1 (en) * 2006-08-11 2012-03-29 박용진 A composition comprising novel black ginseng leaf and the extract thereof showing anti-oxidative activity prepared by novel process
WO2008075866A1 (en) * 2006-12-18 2008-06-26 Yong Jin Park A composition comprising the processed extract of panax quinquefolium l. for the prevention and treatment of cancer
CN101278954A (en) * 2007-04-04 2008-10-08 赵方林 Ginseng or American ginseng product with increased content of ginseng saponin Rg3 and method of preparing the same
KR100920661B1 (en) * 2007-10-23 2009-10-08 한국한방식품공사주식회사 Black ginseng with high saponin content and method for producing the same.
KR20090095354A (en) * 2008-03-05 2009-09-09 주식회사 엔유씨전자 Black ginseng making apparatus and method for making black ginseng using the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005089A (en) * 2002-11-15 2003-01-15 김항종 Manufacturing method of black ginseng and black rice
KR100600795B1 (en) * 2006-01-18 2006-07-19 (주) 흑삼코리아 Black ginseng and black ginseng concentrate with high content of ginsenosides
KR100754253B1 (en) * 2006-05-17 2007-09-03 충남대학교산학협력단 Novel black ginseng manufacturing method and composition containing same
KR100692294B1 (en) * 2006-08-31 2007-03-12 박춘자 Manufacturing method of black ginseng extract excellent in anticancer effect against colorectal cancer
KR100729214B1 (en) * 2006-11-07 2007-06-19 (주)고려바이오홍삼 Manufacturing method of black ginseng and black ginseng prepared using the same
KR20080106077A (en) * 2007-05-31 2008-12-04 박용진 Novel black red ginseng and preparation method thereof and composition containing same
KR20090093310A (en) * 2008-02-29 2009-09-02 강신정 Benzopyrene reduced red and black ginseng manufacturing method

Also Published As

Publication number Publication date
CN102711779A (en) 2012-10-03
KR100972941B1 (en) 2010-07-29
WO2011043564A2 (en) 2011-04-14

Similar Documents

Publication Publication Date Title
WO2009125964A3 (en) Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases
WO2011082270A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
WO2010078421A8 (en) Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2008097640A3 (en) Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
WO2011082266A3 (en) Substituted heterocyclic compounds
WO2011037643A3 (en) Compositions and methods for detecting and treating prostate carcinoma
WO2011146879A3 (en) Methods and compositions related to modulating autophagy
WO2007139967A3 (en) Triazole compounds that modulate hsp90 activity
WO2007139955A3 (en) Triazole compounds that modulate hsp90 activity
WO2006037024A3 (en) Salts of decitabine
WO2008105852A3 (en) Mucoadhesive nanoparticles for cancer treatment
WO2011056021A3 (en) Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis
WO2006034154A3 (en) Salts of 5-azacytidine
WO2007109279A3 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
WO2012134194A3 (en) Herbal compositions for treating neurological diseases and improving memory impairment
WO2012012278A3 (en) Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
EP2353603A4 (en) Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
MX2023010915A (en) Methods for preparing cyclooctenes and conjugates thereof.
WO2011043564A3 (en) Composition containing black ginseng extracts for preventing or treating liver cancer
EP2335712A4 (en) Composition for preventing or treating liver diseases, containing plant stem cell lines derived from the cambium of panax ginseng including mountain ginseng or ginseng as active ingredient
WO2012170742A3 (en) Treatment and prevention of cancer with hmgb1 antagonists

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080055459.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822209

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10822209

Country of ref document: EP

Kind code of ref document: A2